Buy KLOW Blend Peptide — KLOW 80 mg Research Blend

GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg

Researchers looking to buy KLOW Blend Peptide can order the KLOW 80 mg research blend from Royal Peptides. This four-component formulation combines GHK-Cu, BPC-157, TB-500, and KPV in one lyophilized research vial, providing a total labeled content of 80 mg.

KLOW is designed exclusively for laboratory and analytical research and provides a convenient option for researchers requiring a predefined multi-peptide formulation.

KLOW 80 mg Blend Composition

Each KLOW Blend Peptide vial contains:

GHK-Cu — 50 mg
BPC-157 — 10 mg
TB-500 — 10 mg
KPV — 10 mg
Total — 80 mg

What Is KLOW Blend Peptide?

KLOW is a four-component peptide research blend consisting of GHK-Cu, BPC-157, TB-500, and KPV.

The formulation is centered around 50 mg of GHK-Cu, with an additional 10 mg each of BPC-157, TB-500, and KPV. Combining these materials into a single vial provides researchers with a standardized composition for laboratory investigation of multi-component peptide systems.

GHK-Cu — 50 mg

GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycyl-L-histidyl-L-lysine complexed with copper.

Laboratory and preclinical research has examined GHK-Cu in relation to extracellular matrix biology, cellular signaling, collagen-associated processes, and other tissue-model systems.

GHK-Cu is the primary component of KLOW, accounting for 50 mg of the total 80 mg formulation.

BPC-157 — 10 mg

BPC-157 is a synthetic peptide investigated primarily in preclinical research. Experimental studies have explored BPC-157 in areas including cellular signaling, angiogenesis-related mechanisms, gastrointestinal tissue models, and tissue-repair pathways.

KLOW contains 10 mg of BPC-157 per vial.

TB-500 — 10 mg

TB-500 is commonly used as a research designation for thymosin beta-4-related peptide material.

Thymosin beta-4-related research has examined actin-associated processes, cellular migration, angiogenesis, and tissue-remodeling mechanisms in experimental systems.

Each KLOW 80 mg vial contains 10 mg of TB-500.

KPV — 10 mg

KPV is the short tripeptide sequence Lys-Pro-Val associated with the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH).

Preclinical research has investigated KPV in connection with inflammatory signaling and cellular-response pathways.

Each vial contains 10 mg of KPV.

KLOW Peptide Blend Research

The individual components contained in KLOW have been investigated across several areas of laboratory and preclinical research, including:

• Cellular signaling pathways
• Extracellular matrix research
• Collagen-associated biological processes
• Cell migration
• Angiogenesis-related mechanisms
• Tissue-model research
• Inflammatory signaling pathways
• Multi-component peptide research

These areas represent subjects of laboratory investigation and do not establish therapeutic effects or clinical uses.

Buy KLOW 80 mg Research Blend

Royal Peptides offers KLOW 80 mg Blend Peptide for qualified laboratory and analytical research.

Each vial provides the complete four-component formulation:

50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 + 10 mg KPV

Researchers choosing to buy KLOW Blend Peptide should confirm the labeled composition and applicable batch documentation before beginning laboratory work.

KLOW 80 mg Product Specifications

Product Name: KLOW Blend Peptide
Total Strength: 80 mg
GHK-Cu: 50 mg
BPC-157: 10 mg
TB-500: 10 mg
KPV: 10 mg
Form: Lyophilized research material
Packaging: Sealed research vial
Intended Use: Laboratory research only

Quality & Batch Documentation

Royal Peptides emphasizes product identification, batch traceability, and analytical documentation for its research materials.

Applicable third-party analytical documentation may be reviewed through the Royal Peptides COA library. Researchers should verify the batch identifier on their vial against the corresponding documentation.

KLOW Blend Peptide FAQ

What is KLOW Blend Peptide?

KLOW is a multi-component research formulation combining GHK-Cu, BPC-157, TB-500, and KPV within one vial.

How much peptide is in KLOW?

KLOW contains 80 mg total labeled material: 50 mg GHK-Cu plus 10 mg each of BPC-157, TB-500, and KPV.

Where can researchers buy KLOW Blend Peptide?

Royal Peptides offers KLOW 80 mg Blend Peptide as a research-use-only laboratory material with batch identification and applicable analytical documentation.

Is KLOW the same as GHK-Cu?

No. GHK-Cu is the largest component of KLOW, but KLOW is a four-component blend containing GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg, and KPV 10 mg.

Is KLOW intended for human use?

No. KLOW is sold strictly for laboratory and analytical research. It is not intended for human or veterinary administration.

Order KLOW Blend Peptide for Research

Researchers seeking to buy KLOW Blend Peptide online can select Royal Peptides KLOW 80 mg for a clearly identified four-component research formulation containing GHK-Cu, BPC-157, TB-500, and KPV.

For Research Use Only (RUO). Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.